| BUSINESS INFORMATION | reported earnings per share of $4.63 for its fiscal 2002, compared with $1.66 for fiscal 2001 |
| CLASSIFICATION | Market |
| OBSERVATION'S | When Co.`s exclusivity on drug expired, 18 other companies jumped in, and prices plummeted in the ensuing bloodbath. |
| SALES VALUE |
it made $311 million in the first six months. But when the exclusivity ended, sales dropped to $54 million in months seven through nine, and sank to $2.5 million in months 10 through 12. |
| UPDATE | 09.02 |
| LITERATURE REF. | This data is not available for free |
| MARKETING BY | This data is not available for free |
| PRODUCTION BY | This data is not available for free |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |